Straumann Holding AG/€STMN

1D1W1MYTD1Y5YMAX

About Straumann Holding AG

Straumann Holding AG is a global company specializing in the manufacture and supply of dental implants, orthodontic products, and digital dentistry tools. Headquartered in Basel, Switzerland, the company's products include dental implants, prosthetics, digital equipment, and biomaterials, serving both dental professionals and patients worldwide. Straumann has grown through strategic acquisitions, expanding its footprint in digital and orthodontic technologies. The company operates in various international markets, leveraging a strong focus on innovation and partnerships to maintain its competitive advantage in the dental industry. Its strategic positioning is supported by a commitment to research and development, ensuring continuous advancements in dental solutions.
Ticker
€STMN
Sector
Health
Primary listing
XGAT
Employees
11,582
Headquarters
Basel, Switzerland
Website
www.straumann.com

STMN Metrics

BasicAdvanced
€16B
41.56
€2.44
1.38
€1.09
1.07%

Bulls say / Bears say

Swiss dental implants maker Straumann reported H1 2026 revenue of CHF 1.38 billion, in line with consensus and slightly exceeding its core EBIT consensus of CHF 355 million versus CHF 350 million expected (Reuters).
Management reaffirmed its full-year 2026 targets of high single-digit organic revenue growth and 140–170 basis point expansion in core EBIT margin at constant exchange rates, demonstrating confidence in its strategic execution (Reuters).
Strong customer adoption of the SIRIOS X3 intraoral scanner and rapid scaling of the cloud-based Straumann AXS platform expanded the company’s digital ecosystem, setting the stage for recurring consumables and workflow revenues (Straumann press release).
Significant foreign exchange headwinds in Q1 2026 led to a 1.2 percent decline in reported revenue in Swiss francs despite organic growth of 7.1 percent, highlighting currency risk to top-line figures (Straumann Q1 press release).
Currency effects trimmed reported core EBIT margin by approximately 120 basis points, from 26.9 percent at constant exchange rates to 25.7 percent including FX impacts, underscoring profit sensitivity to currency volatility (FT Markets).
The upcoming rollout of China’s VBP 2.0 volume-based procurement in H2 2026 poses renewed pricing pressure and competitive risk from local manufacturers, potentially eroding margins in the Asia-Pacific region (Straumann press release).
Data summarised monthly by Lightyear AI. Last updated on 7 Sept 2026.

Funds containing STMN

Funds
Fund name
Fund size
€STMN weighting
WisdomTree Global Quality Dividend Growth£GGRG
£1.9B0.05%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.